Cargando…
Encephalopathy Due to COVID-19 With Great Response to Glucocorticoids
Minor neurological symptoms such as anosmia are relatively common manifestations of coronavirus disease 2019 (COVID-19). However, severe affection of the central nervous system (CNS) occurs in a minority of cases and its treatment and pathophysiology is not yet well understood. It has been described...
Autores principales: | Pizzato Tondo, Lucca, Beck Paglioli Neto, Eduardo, Arpini, Soel, Passos, Giordani, Becker, Jefferson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501896/ https://www.ncbi.nlm.nih.gov/pubmed/34660051 http://dx.doi.org/10.7759/cureus.17845 |
Ejemplares similares
-
Editorial: Advances in Steroid-Responsive Encephalopathy
por: Tian, Xin, et al.
Publicado: (2020) -
A Case of Early Infantile Epileptic Encephalopathy Due to KCNQ2 Gene Mutation Presenting With Episodes of Hiccups
por: Alan, Serdar, et al.
Publicado: (2022) -
Clinical and Genetic Characteristics of Mitochondrial Encephalopathy Due to FOXRED1 Mutations: Two Chinese Case Reports and a Review of the Literature
por: Hu, Chaoping, et al.
Publicado: (2021) -
Hashimoto's Encephalopathy and Seizure Disorders
por: Li, Jie, et al.
Publicado: (2019) -
Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy
por: Filatov, Asia, et al.
Publicado: (2020)